GSTDTAP  > 地球科学
DOI10.1038/s41586-020-2295-8
Structure of nevanimibe-bound tetrameric human ACAT1
Ma, Xiyu1,2; Claus, Lucas A. N.3,4; Leslie, Michelle E.5,11; Tao, Kai6,7; Wu, Zhiping8,9; Liu, Jun1,2; Yu, Xiao2; Li, Bo2,10; Zhou, Jinggeng1,2; Savatin, Daniel V.3,4; Peng, Junmin8,9; Tyler, Brett M.6,7; Heese, Antje5; Russinova, Eugenia3,4; He, Ping1,2; Shan, Libo2,10
2020-05-01
发表期刊NATURE
ISSN0028-0836
EISSN1476-4687
出版年2020
卷号581期号:7808页码:339-U214
文章类型Article
语种英语
国家USA
英文关键词

The structure of human ACAT1 in complex with the inhibitor nevanimibe is resolved by cryo-electron microscopy.


Cholesterol is an essential component of mammalian cell membranes, constituting up to 50% of plasma membrane lipids. By contrast, it accounts for only 5% of lipids in the endoplasmic reticulum (ER)(1). The ER enzyme sterol O-acyltransferase 1 (also named acyl-coenzyme A:cholesterol acyltransferase, ACAT1) transfers a long-chain fatty acid to cholesterol to form cholesteryl esters that coalesce into cytosolic lipid droplets. Under conditions of cholesterol overload, ACAT1 maintains the low cholesterol concentration of the ER and thereby has an essential role in cholesterol homeostasis(2,3). ACAT1 has also been implicated in Alzheimer' s disease(4), atherosclerosis(5) and cancers(6). Here we report a cryo-electron microscopy structure of human ACAT1 in complex with nevanimibe(7), an inhibitor that is in clinical trials for the treatment of congenital adrenal hyperplasia. The ACAT1 holoenzyme is a tetramer that consists of two homodimers. Each monomer contains nine transmembrane helices (TMs), six of which (TM4-TM9) form a cavity that accommodates nevanimibe and an endogenous acyl-coenzyme A. This cavity also contains a histidine that has previously been identified as essential for catalytic activity(8). Our structural data and biochemical analyses provide a physical model to explain the process of cholesterol esterification, as well as details of the interaction between nevanimibe and ACAT1, which may help to accelerate the development of ACAT1 inhibitors to treat related diseases.


领域地球科学 ; 气候变化 ; 资源环境
收录类别SCI-E
WOS记录号WOS:000532688300009
WOS关键词COA-CHOLESTEROL ACYLTRANSFERASE ; ACYL-COENZYME ; O-ACYLTRANSFERASES ; IDENTIFICATION ; EXPRESSION ; INHIBITOR ; CLONING ; DOMAIN ; CELLS ; MODEL
WOS类目Multidisciplinary Sciences
WOS研究方向Science & Technology - Other Topics
引用统计
被引频次:49[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://119.78.100.173/C666/handle/2XK7JSWQ/281035
专题地球科学
资源环境科学
气候变化
作者单位1.Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA;
2.Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA;
3.Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium;
4.VIB, Ctr Plant Syst Biol, Ghent, Belgium;
5.Univ Missouri, Dept Biochem, Interdisciplinary Plant Grp, Columbia, MO USA;
6.Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA;
7.Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA;
8.St Jude Childrens Res Hosp, Ctr Prote & Metabol, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA;
9.St Jude Childrens Res Hosp, Ctr Prote & Metabol, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA;
10.Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA;
11.Elemental Enzymes, St Louis, MO USA
推荐引用方式
GB/T 7714
Ma, Xiyu,Claus, Lucas A. N.,Leslie, Michelle E.,et al. Structure of nevanimibe-bound tetrameric human ACAT1[J]. NATURE,2020,581(7808):339-U214.
APA Ma, Xiyu.,Claus, Lucas A. N..,Leslie, Michelle E..,Tao, Kai.,Wu, Zhiping.,...&Shan, Libo.(2020).Structure of nevanimibe-bound tetrameric human ACAT1.NATURE,581(7808),339-U214.
MLA Ma, Xiyu,et al."Structure of nevanimibe-bound tetrameric human ACAT1".NATURE 581.7808(2020):339-U214.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Ma, Xiyu]的文章
[Claus, Lucas A. N.]的文章
[Leslie, Michelle E.]的文章
百度学术
百度学术中相似的文章
[Ma, Xiyu]的文章
[Claus, Lucas A. N.]的文章
[Leslie, Michelle E.]的文章
必应学术
必应学术中相似的文章
[Ma, Xiyu]的文章
[Claus, Lucas A. N.]的文章
[Leslie, Michelle E.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。